Skip to main content
. 2022 Mar 4;14(5):1334. doi: 10.3390/cancers14051334
ACS American College of Surgeons
ARDS acute respiratory distress syndrome
ASCO American Society of Clinical Oncology
BTS British Thoracic Society
CCC-19 COVID-19 and Cancer Consortium
CI confidence interval
CT computed tomography
COPD chronic obstructive pulmonary disease
COVID-19 coronavirus disease 2019
CRT chemoradiation therapy
ESMO European Society for Medical Oncology
GCO Groupes Coopérateurs en Oncologie
GM-CSF granulocyte macrophage colony-stimulating factor
IASCL International Association for the Study of Lung Cancer
ICU intensive care unit
IL interleukin
MSKCC Memorial Sloan Kettering Cancer Center
NK natural killer
NSCLC non-small cell lung cancer
OS overall survival
PAI plasminogen activator inhibitor
PPE personal protective equipment
RR relative risk
SARS-CoV-2 severe acute respiratory syndrome coronavirus 2
SBRT stereotactic body radiation therapy
TERAVOLT Thoracic Cancers International COVID-19 Collaboration
TME tumor microenvironment
TNF tumor necrosis factor
UKCCMP UK Coronavirus Cancer Monitoring Project